Finance Systems Manager, FP&A jobs in United States
cer-icon
Apply on Employer Site
company-logo

Intellia Therapeutics, Inc. · 2 weeks ago

Finance Systems Manager, FP&A

Intellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. They are seeking a highly skilled Finance Systems Manager to manage budget consolidations, reporting, and administration of financial tools, while also developing analytics to support the business.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Manage the budget and forecast consolidations for the business
Manage our monthly total company reporting
Serve as an administrator for both our Adaptive Planning tool as well as our Enterprise Data Warehouse (EDW) dashboard
Help continue to evolve our internal reporting packages
Develop robust reporting and analytics to support the Business

Qualification

Adaptive PlanningPowerBIOracleFinancial Planning SystemsUS GAAPExcel/VBAFinancial AnalysisSQLPythonBiotech ExperienceProcess ImprovementCommunication

Required

BS/BA in Accounting or Finance
6+ years of progressive financial analysis experience
Advanced level user in MS office particularly Excel/VBA, PowerPoint and PowerBI
Admin level experience in Financial Planning and ERP Systems
Experience with Artificial Intelligence for reporting and reconciliations
Financial statement knowledge and understanding of US GAAP
Motivated self-starter who is detailed, results and process-oriented
Strong communicator comfortable leading across functions and collaborative teams
Able to interpret, present and explain complex finance issues to various business partners

Preferred

SQL/Python is a plus
Biotech experience is a plus

Benefits

Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards

Company

Intellia Therapeutics, Inc.

company-logo
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

H1B Sponsorship

Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)

Funding

Current Stage
Public Company
Total Funding
$1.54B
Key Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M

Leadership Team

leader-logo
John Leonard
President and Chief Executive Officer, Member Board of Directors
linkedin
leader-logo
Edward Dulac
Chief Financial Officer
linkedin
Company data provided by crunchbase